ITEM#: 3042-161287820MG
MFR#: 1612878-20MG
Sibutramine Related Compound C United States Pharmacopeia (USP) Reference Standard
Product Name | Description | Item# | QTY | |
---|---|---|---|---|
Sibutramine Related Compound A | Sibutramine Related Compound A United States Pharmacopeia (USP) Reference Standard | 3042-161285620MG | EA | |
Sibutramine Related Compound B | Sibutramine Related Compound B United States Pharmacopeia (USP) Reference Standard | 3042-161286720MG | EA | |
Allopurinol Related Compound C | Allopurinol Related Compound C United States Pharmacopeia (USP) Reference Standard | 3042-101303525MG | EA | |
Oxycodone Related Compound C | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issui | 3042-148523815MG | EA | |
Trandolapril Related Compound C | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-167270125MG | EA | |
Econazole Related Compound C | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-123185215MG | EA | |
Glipizide Related Compound C | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-129263115MG | EA | |
Zonisamide Related Compound C | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-172503620MG | EA | |
Dalfampridine Related Compound C | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-116256725MG | EA |
Thank you for visiting, your account is pending approval.
You will received email notification for approval within 24hrs.
Contact customerservice@franklinyoung.com for any questions.
Thank you for requesting an account with Franklin Young.
Your request has been declined
We restrict website access to government entities, and related customers.
Please contact customerservice@franklinyoung.com with any questions.